Human scalp permeability to the chemical warfare agent VX

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 1974-1980

  Rolland, P ^a,b   Bolzinger, M A ^a,c,d,e   Cruz, C ^c   Briancon S ^a   Josse, D ^c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Institut des Sciences Pharmaceutiques et Biologiques   (France)

^e INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Hair follicle; Human scalp skin; In vitro; Percutaneous penetration; Pig ear; VX

Indexed keywords

METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER;

ABDOMINAL SKIN; ARTICLE; CHEMICAL WARFARE; CONTROLLED STUDY; EAR SKIN; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; LIPOPHILICITY; NONHUMAN; SCALP; SKIN; SKIN ABSORPTION; SKIN PERMEABILITY; SKIN SURFACE; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE;

ABDOMEN; ADULT; ANIMALS; CHEMICAL WARFARE AGENTS; EAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, ANIMAL; ORGANOTHIOPHOSPHORUS COMPOUNDS; PERMEABILITY; SCALP; SKIN; SKIN ABSORPTION; SKULL; SWINE; YOUNG ADULT;

SUIDAE;

EID: 82655162164     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.06.021     Document Type: Article

References (50)

1. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. Skin penetration and distribution of polymeric nanoparticles. Journal of Controlled Release 2004, 99:53-62.
2. Bertrand, C., Ammirati, C., Renaudu, C., Les principaux agents chimiques. Risques chimiques: accidents, attentats. Elsevier (Ed.), 2006, pp. 66-77.
3. Blume-Peytavi U., Massoudy L., Patzelt A., Lademann J., Dietz E., Rasulev U., Garcia Bartels N. Follicular and percutaneous penetration pathways of topically applied minoxidil foam. European Journal of Pharmaceutics and Biopharmaceutics 2010, 76:450-453.
4. Bolzinger M., Briançon S., Pelletier J., Fessi H., Chevalier Y. Percutaneous release of caffeine from microemulsion emulsion and gel dosage forms. European Journal of Pharmaceutics and Biopharmaceutics 2008, 68:446-451.
5. Braue E.H., Smith K.H., Doxzon B.F., Lumpkin H.L., Clarkson E.D. Efficacy studies of reactive skin decontamination lotion, m291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 1: guinea pigs challenged with VX. Cutaneous Ocular Toxicology 2011, 30:15-28.
6. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., Hamilton M.G. In vivo skin absorption and distribution of the nerve agent VX (o-ethyl-s-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Human and Experimental Toxicology 2005, 24:347-352.
7. Craig F.N., Cummings E.G., Sim V.M. Environmental temperature and the percutaneous absorption of a cholinesterase inhibitor VX. Journal of Investigative Dermatology 1977, 68:357-361.
8. Czerwinski S.E., Skvorak J.P., Maxwell D.M., Lenz D.E., Baskin S.I. Effect of octanol: water partition coefficients of organophosphorus compounds on biodistribution and percutaneous toxicity. Journal of Biochemical and Molecular Toxicology 2006, 20:241-246.
9. Dalton C., Hattersley I., Rutter S., Chilcott R. Absorption of the nerve agent VX (o-ethyl-s-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicology In Vitro 2006, 20:1532-1536.
10. Dick I., Scott R. Pig ear skin as an in vitro model for human skin permeability. Journal of Pharmacy and Pharmacology 1992, 44:640-645.
11. Grams Y., Whitehead L., Cornwell P., Bouwstra J. Time and depth resolved visualization of the diffusion of a lipophilic dye into the hair follicle of fresh human scalp skin. Journal of Controlled Release 2004, 98:367-378.
12. Grams Y.Y., Whitehead L., Cornwell P., Bouwstra J. On-line visualization of dye diffusion in fresh unfixed human skin. Pharmaceutical Research 2004, 21:851-859.
13. Guy R.H., Potts R.O. Structure-permeability relationships in percutaneous penetration. Journal of Pharmaceutical Sciences 1992, 81:603-604.
14. Hueber-Becker F., Nohynek G.J., Meuling W.J.A., Benech-Kieffer F., Toutain H. Human systemic exposure to a [14c]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. Food and Chemical Toxicology 2004, 42:1227-1236.
15. Jacobi U., Taube H., Schafer U., Sterry W., Lademann J. Comparison of four different in vitro systems to study the reservoir capacity of the stratum corneum. Journal of Controlled Release 2005, 103:61-71.
16. Jacobi U., Kraiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., Sterry W., Lademann J. Porcine ear skin: an in vitro model for human skin. Skin Research and Technology 2007, 13:19-24.
17. Joseph R., Tsai W., Tsao L., Su T., Cone E. In vitro characterization of cocaine binding sites in human hair. The Journal of Pharmacology and Experimental Therapeutics 1997, 282:1128-1241.
18. Knorr F., Lademann J., Patzelt A., Sterry W., Blume-Peytavi U., Vogt A. Follicular transport route - research progress and future perspectives. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71:173-180.
19. Lademann J., Richter H., Schaefer U.F., Blume-Peytavi U., Teichmann A., Otberg N., Sterry W. Hair follicles - a long-term reservoir for drug delivery. Skin Pharmacology and Skin Physiology 2006, 19:232-236.
20. Lademann J., Knorr F., Richter H., Blume-Peytavi U., Vogt A., Antoniou C., Sterry W., Patzelt A. Hair follicles - an efficient storage and penetration pathway for topically applied substances. Skin Pharmacology and Skin Physiology 2008, 21:150-155.
21. Lademann J., Richter H., Jacobi U., Patzelt A., Hueber-Becker F., Ribaud C., Benech-Kieffer F., Dufour E., Sterry W., Schaefer H., Leclaire J., Toutain H., Nohynek G. Human percutaneous absorption of a direct hair dye comparing in vitro and in vivo results: implications for safety assessment and animal testing. Food and Chemical Toxicology 2008, 46:2214-2223.
22. Lademann J., Patzelt A., Richter H., Schanzer S., Sterry W., Filbry A., Bohnsack K., Rippke F., Meinke M. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. European Journal of Pharmaceutics and Biopharmaceutics 2009, 72:600-604.
23. Lademann J., Patzelt A., Schanzer S., Richter H., Gross I., Menting K.H., Frazier L., Sterry W., Antoniou C. Decontamination of the skin with absorbing materials. Skin Pharmacology and Physiology 2011, 24:87-92.
24. Le Guevel, E., 1997. Substitution nucléophile de composés organophosphorés par les ions oximate. Application en décontamination douce. Université de Versailles-Saint-Quentin-En-Yvelines. Thèse de Doctorat.
25. Loke W.K., Karlsson B., Waara L., Nyberg A.G., Cassel G.E. Enzyme-based microassay for accurate determination of soman in blood samples. Analytical Biochemistry 1998, 257:12-19.
26. Maibach H.I., Feldman R.J., Milby T.H., Serat W.F. Regional variation in percutaneous penetration in man. Pesticides Archives in Environmental Health 1971, 23:208-211.
27. Meyer W., Zschemisch N., Godynicki S. The porcine ear skin as a model system for the human integument: influence of storage conditions on basic features of epidermis structure and function - a histological and histochemical study. Polish Journal of Veterinary Sciences 2003, 6:17-28.
28. Millerioux J., Cruz C., Bazire A., Lallement G., Lefeuvre L., Josse D. In vitro selection and efficacy of topical skin protectants against the nerve agent VX. Toxicology in Vitro 2009, 23:539-545.
29. Mowafi M., Cassens R. Microscopic structure of pig skin. Journal of Animal Science 1975, 41:1281-1290.
30. Munro N. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environmental Health Perspectives 1994, 102:18-38.
31. Ogiso T., Shiraki T., Okajima K., Tanino T., Iwaki M., Wada T. Transfollicular drug delivery: penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro. Journal of Drug Targeting 2002, 10:369-378.
32. Otberg N., Richter H., Knuttel A., Schaefer H., Sterry W., Lademann J. Laser spectroscopic methods for the characterization of open and closed follicles. Laser Physics Letters 2004, 1:46-49.
33. Otberg N., Richter H., Schaefer H., Blume-Peytavi U., Sterry W., Lademann J. Variations of hair follicle size and distribution in different body sites. Journal of Investigative Dermatology 2004, 122:14-19.
34. Otberg N., Patzelt A., Rasulev U., Hagemeister T., Linscheid M., Sinkgraven R., Sterry W., Lademann J. The role of hair follicles in the percutaneous absorption of caffeine. British Journal of Clinical Pharmacology 2008, 65:488-492.
35. Patzelt A., Richter H., Buettemeyer R., Huber H.J.R., Blume-Peytavi U., Sterry W., Lademann J. Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. European Journal of Pharmaceutics and Biopharmaceutics 2008, 70:234-238.
36. Prost-Squarcioni C. Histology of skin and hair follicle. Medicine Science (Paris) 2006, 22:131-137.
37. Pötsch L., Moeller M.R. On pathways for small molecules into and out of human hair fibers. Journal of Forensic Sciences 1996, 41:121-125.
38. Ran G., Zhang Y., Song Q., Wang Y., Cao D. The adsorption behavior of cationic surfactant onto human hair fibers. Colloids Surface B Biointerfaces 2009, 68:106-110.
39. Ritschel W.A., Sabouni A., Hussain A.S. Percutaneous absorption of coumarin, griseofulvin and propranolol across human scalp and abdominal skin. Methods and Findings in Experimental and Clinical Pharmacology 1989, 11:643-646.
40. Rougier A., Dupuis D., Lotte C., Roguet R. The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: influence of application time. Journal of Investigative Dermatology 1985, 84:66-68.
41. Rougier A., Lotte C., Maibach H.I. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. Journal of Pharmaceutical Sciences 1987, 76:451-454.
42. Simon G., Maibach H. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin pharmacology and Applied Skin Physiology 2000, 13:229-234.
43. Teichmann A., Jacobi U., Ossadnik M., Richter H., Koch S., Sterry W., Lademann J. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. Journal of Investigative Dermatology 2005, 125:264-269.
44. Teichmann A., Otberg N., Jacobi U., Sterry W., Lademann J. Follicular penetration: development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacology and Applied Skin Physiology 2006, 19:216-223.
45. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. Journal of Investigative Dermatology 2004, 123:168-176.
46. Trauer S., Patzelt A., Otberg N., Knorr F., Rozycki C., Balizs G., Büttemeyer R., Linscheid M., Liebsch M., Lademann J. Permeation of topically applied caffeine through human skin - a comparison of in vivo and in vitro data. British Journal of Clinical Pharmacology 2009, 68:181-186.
47. Vallet V., Cruz C., Licausi J., Bazire A., Lallement G., Boudry I. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin. Validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations. Toxicology 2008, 246:73-82.
48. Vogt A., Hadam S., Heiderhoff M., Audring H., Lademann J., Sterry W., Blume-peytavi U. Morphometry of human terminal and vellus hair follicles. Experimental Dermatology 2007, 16:946-950.
49. Wosicka H., Cal K. Targeting to the hair follicles: current status and potential. Journal of Dermatological Science 2010, 57:83-89.
50. Yanagisawa N., Morita H., Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. Journal of Neurological Sciences 2006, 249:76-85.